Life Summary
Kim Yi-rang is the Chief Executive Officer of Oncocross.

He is focusing on leveraging the company’s AI drug development platform, RAPTOR AI, to expand into the global market.

He is also diversifying the company’s portfolio with a new cancer diagnostics venture.
He was born on November 30, 1980.

He graduated from the Department of Medicine at Chosun University, earned a master’s degree from the Graduate School of the University of Ulsan, and received a Ph.D. from the KAIST Graduate School of Medical Science and Engineering.

He completed his residency in internal medicine and fellowship in oncology at Asan Medical Center in Seoul. In 2015, while serving as Chief of the Hematology-Oncology Department at Daejeon Yuseong Sun Hospital, he founded Oncocross.

As a physician-scientist, he places patients at the center of his work. He founded the company out of a desire to develop therapies tailored to each patient.

He also serves as president of the AI Drug Development Council.